Ireland
--:--IST
Active, not recruiting Not applicable

Cryotherapy for Reducing Fistula Puncture Pain in Hemodialysis Patients

NCT07694271 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2025-02-25
Last updated
2026-07-27

Condition(s) studied

Pain, Procedural (During Sternum Dressing on Infants)Arteriovenous FistulaKidney Failure, Chronic

Investigational drug(s) / intervention(s)

Usual Care (Room-Temperature Water Bag)Cryotherapy (Ice Pack)Lidocaine/Prilocaine Gel →

Usual Care (Room-Temperature Water Bag): Placement of a room-temperature water bag at the puncture site for 5 minutes before cannulation.

Cryotherapy (Ice Pack): Application of a 200g ice pack wrapped in a single layer of cotton cloth to the LI4 (Hegu) acupoint on the non-fistula hand for 5 minutes before cannulation.

Lidocaine/Prilocaine Gel: Topical application of lidocaine/prilocaine gel to two puncture areas under an occlusive dressing for up to 1 hour before cannulation.

Study summary

People on hemodialysis need their arteriovenous fistula (a blood vessel access point) punctured with a needle three times a week, which can cause pain and worry. This study compares three ways of managing that pain: (1) usual care, (2) applying an ice pack to a specific point on the hand before the needle is inserted (cryotherapy), and (3) applying a numbing gel (lidocaine/prilocaine) to the skin before the needle is inserted.

Adult hemodialysis patients with a working fistula were randomly assigned to one of these three groups. Over three dialysis sessions, researchers measured each patient's pain, anxiety, and other symptoms right before, right after, during, and after dialysis, as well as their quality of life and a physical stress marker (heart rate variability). The goal is to find out whether the ice pack method works as well as or better than usual care and the numbing gel at reducing pain and anxiety, so that a simple, low-cost, non-drug option could be offered to more patients in the future.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * Diagnosed with end-stage renal disease requiring long-term hemodialysis * Receiving hemodialysis with no hospitalization or arteriovenous fistula-related complications (e.g., infection, steal syndrome, aneurysm, pseudoaneurysm) within the past month * Has a functioning arteriovenous fistula access (adequate vessel diameter, elastic and intact vessel wall, no significant stenosis or occlusion, superficial location, healthy surrounding tissue) * Clear consciousness and able to express pain sensation, with no psychiatric symptoms interfering with communication * Able to communicate in Mandarin or Taiwanese Exclusion Criteria: * Not using an arteriovenous fistula for dialysis vascular access * History of stroke or peripheral neuropathy/sensory abnormality (e.g., numbness, tingling) * Confused consciousness, unable to clearly express pain sensation * Dysfunctional fistula, deep vein thrombosis, or cannulation difficulty preventing full use of the arteriovenous fistula

Primary outcome measure(s)

  • Puncture-Related Pain Severity — Measured at 4 time points (pre-puncture, post-puncture, during dialysis, post-dialysis) over each of 3 consecutive hemodialysis sessions, up to approximately 1 week
    Pain severity related to arteriovenous fistula puncture, assessed using the pain item of the Edmonton Symptom Assessment Scale-revised (ESAS-r), a 0-10 numeric rating scale where higher scores indicate greater pain severity.

Trial sites (1)

FacilityCityRegionStatus
Taipei Municipal Wanfang Hospital Taipei Taiwan
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07694271 on ClinicalTrials.gov ↗ ← All trials in Taiwan